Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

betrixaban

betrixaban
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Bevyxxa TABLET, ORAL 40 mg, 80 mg    
Comments:
ORDERED FORMULATION THERAPEUTIC INTERCHANGE

betrixaban (Bevyxxa)

  • 160 mg PO x1, then 80 mg daily
  • 80 mg PO daily
  • 80 mg PO x1, then 40 mg daily
  • 40 mg PO daily

prophylactic enoxaparin (Lovenox)

  • 40 mg subcutaneously daily
  • 40 mg subcutaneously daily
  • 30 mg subcutaneously daily
  • 30 mg subcutaneously daily

Bevyxxa medication guide

Bevyxxa is non-formulary with an automatic interchange to Lovenox.  Lovenox renal dosing adjustments as needed.

Reviewed: 27 March 2018 (Bevyxxa)

Last updated: Dec. 6, 2019






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved